Sigma Planning Corp Biogen Inc. Transaction History

Sigma Planning Corp

$3.16 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	SELL	$252.44 - $306.72 $185,543 - $225,439	-735 Reduced 43.67%	948 $0
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $6,230 - $8,590	-32 Reduced 1.87%	1,683 $449,000
Q2 2022 Aug 11, 2022	SELL	$187.54 - $223.02 $14,628 - $17,395	-78 Reduced 4.35%	1,715 $350,000
Q1 2022 Apr 20, 2022	BUY	$193.77 - $244.14 $347,429 - $437,743	1,793 New	1,793 $378,000
Q3 2021 Oct 28, 2021	SELL	$282.99 - $369.05 $669,271 - $872,803	-2,365 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $233,877 - $374,483	-903 Reduced 27.63%	2,365 $819,000
Q1 2021 May 06, 2021	BUY	$242.95 - $284.63 $62,924 - $73,719	259 Added 8.61%	3,268 $914,000
Q4 2020 Feb 09, 2021	BUY	$236.26 - $355.63 $439,916 - $662,183	1,862 Added 162.34%	3,009 $737,000
Q3 2020 Nov 03, 2020	SELL	$264.77 - $305.71 $62,220 - $71,841	-235 Reduced 17.0%	1,147 $325,000
Q2 2020 Jul 31, 2020	SELL	$258.66 - $342.55 $50,956 - $67,482	-197 Reduced 12.48%	1,382 $370,000
Q1 2020 May 01, 2020	BUY	$268.85 - $341.04 $104,313 - $132,323	388 Added 32.58%	1,579 $500,000
Q4 2019 Feb 03, 2020	BUY	$220.06 - $304.07 $262,091 - $362,147	1,191 New	1,191 $353,000
Q3 2019 Nov 01, 2019	SELL	$217.44 - $243.88 $210,699 - $236,319	-969 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$219.29 - $241.72 $212,492 - $234,226	969 New	969 $227,000
Q4 2018 Jan 31, 2019	SELL	$278.5 - $352.75 $225,585 - $285,727	-810 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$293.51 - $383.83 $1,174 - $1,535	4 Added 0.5%	810 $286,000
Q2 2018 Aug 02, 2018	BUY	$257.52 - $306.91 $207,561 - $247,369	806 New	806 $234,000
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $258,569 - $365,702	-994 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$307.64 - $344.58 $71,987 - $80,631	234 Added 30.79%	994 $317,000
Q3 2017 Nov 06, 2017	BUY	$281.15 - $329.69 $213,673 - $250,564	760	760 $238,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Account